Cancer Letters
Volume 206, Issue 2 , Pages 159-167, 8 April 2004

Perspectives on farnesyl transferase inhibitors in cancer therapy

Département Innovation Thérapeutique et Oncologie Moléculaire, INSERM U563, Institut Claudius Regaud, 20-24, rue du pont Saint-Pierre, Toulouse cedex 31052, France

Received 29 July 2003; accepted 5 August 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(03)00635-9

doi:10.1016/j.canlet.2003.08.033

Cancer Letters
Volume 206, Issue 2 , Pages 159-167, 8 April 2004

Article Tools